Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2014
11/27/2014US20140348827 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
11/27/2014US20140348824 Predictive biomarker of survival in the treatment of renal cell carcinoma
11/27/2014US20140348815 Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications
11/27/2014US20140348814 Arginne deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
11/27/2014US20140348813 Thermostabilization of proteins
11/27/2014US20140348812 Protocols for treating and preventing obesity and complications arising therefrom
11/27/2014US20140348810 Absorbable in situ gel-forming system, method of making and use thereof
11/27/2014US20140348807 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field
11/27/2014US20140348805 High affinity t cell receptor and use thereof
11/27/2014US20140348804 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
11/27/2014US20140348800 Modified two-component gelation systems, methods of use and methods of manufacture
11/27/2014US20140348795 Nutritional beverage powder and method of making same
11/27/2014US20140348789 Targeted mutant alpha-helical bundle cytokines
11/27/2014US20140348788 Method to modulate pigmentation process in the melanocytes of skin
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/27/2014US20140348783 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348782 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348781 Conjugates of gm-csf and il-9, compositions and methods related thereto
11/27/2014US20140348780 Method of Enhanced Antibiotic Activity Via Chemotaxis
11/27/2014US20140348778 Reverse thermal gels and their use in cell therapy
11/27/2014US20140348752 Methods for treating lysosomal acid lipase deficiency in patients
11/27/2014US20140348750 Hyperspectral imaging for early detection of alzheimer's disease
11/25/2014US8895806 Fucosyl transferase gene
11/25/2014US8895777 Compounds and compositions for delivering active agents
11/25/2014US8895737 Process for preparing antiviral compounds
11/25/2014US8895722 Splice-region antisense composition and method
11/25/2014US8895721 RNA interference mediating small RNA molecules
11/25/2014US8895718 RNA interference mediating small RNA molecules
11/25/2014US8895714 Biological products
11/25/2014US8895713 Clostridial neurotoxins with altered persistency
11/25/2014US8895711 Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
11/25/2014US8895706 Chromatography matrices including novel Staphylococcus aureus protein A based ligands
11/25/2014US8895701 Peptide-conjugated oligonucleotide therapeutic and method of making and using same
11/25/2014US8895700 Monkey homolog of human interferon omega
11/25/2014US8895698 Binding partners of antibodies specific for dendritic cell antigens
11/25/2014US8895695 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
11/25/2014US8895694 Glucagon-Like Peptide-1 derivatives and their pharmaceutical use
11/25/2014US8895576 Methods of use of cyclopamine analogs
11/25/2014US8895540 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
11/25/2014US8895515 Cosmetic composition for skin cell regeneration mimicking extracellular matrix
11/25/2014US8895514 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
11/25/2014US8895513 Personal care compositions with acidified pectins
11/25/2014US8895512 Composition for improving brain function and method for improving brain function
11/25/2014US8895508 Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles
11/25/2014US8895507 Modulation of synaptogenesis
11/25/2014US8895506 Protein stabilization formulations
11/25/2014US8895505 Method of treatment of type 2 diabetes
11/25/2014US8895504 Amylin derivatives
11/25/2014US8895503 Pharmaceutical composition for transnasal administration of peptide hormones or cytokines
11/25/2014US8895502 β2-glycoprotein I peptide inhibitors
11/25/2014US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
11/25/2014US8895500 Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same
11/25/2014US8895499 β-hairpin peptidomimetics
11/25/2014US8895498 GIP and exendin hybrid polypeptides
11/25/2014US8895303 Method of cell culture and method of treatment comprising a vEPO protein variant
11/25/2014US8895299 Method for expansion of stem cells
11/25/2014US8895286 Attenuated pestiviruses
11/25/2014US8895282 Use of a substance for manufacturing of a medicament for treatment of common cold
11/25/2014US8895263 Methods for suppressing toll-like receptor activity
11/25/2014US8895253 Integrin heterodimer and a subunit thereof
11/25/2014US8895251 Method for detecting human BPLP protein or a maturation product thereof
11/25/2014US8895237 Enhancing of hepatitis B virus vaccine and its gene
11/25/2014US8895081 Formulation for treatment of dry mouth and mouth sores
11/25/2014US8895079 Combinations of botanical extracts for promoting cardiovascular health
11/25/2014US8895077 Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds
11/25/2014US8895062 Surface-layer protein coated microspheres and uses thereof
11/25/2014US8895060 Methods and apparatus for sealing capsules
11/25/2014US8895056 Regional delivery of therapeutic agents for the treatment of vascular diseases
11/25/2014US8895047 Combined fibrinolytic and antimicrobial catheter and uses thereof
11/25/2014US8895033 Sustained release formulations using non-aqueous carriers
11/25/2014US8895027 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
11/25/2014US8895022 Methods of use of soluble CD24 for therapy of rheumatoid arthritis
11/25/2014US8895016 Antagonists of activin-actriia and uses for increasing red blood cell levels
11/25/2014US8895012 sgp130/Fc dimers
11/25/2014US8895011 Insulin-resistance-improving drug
11/25/2014US8895010 Antibody polypeptides that antagonize CD40L
11/25/2014US8895003 Pharmaceutical composition comprising EDA-1 Fusion Protein
11/25/2014US8895002 Hemojuvelin fusion proteins and uses thereof
11/25/2014US8894999 Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
11/25/2014US8894994 Modified beta-lactamases and methods and uses related thereto
11/25/2014US8894993 Mitochondria-targeted antioxidants
11/25/2014US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
11/25/2014US8894977 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound
11/20/2014US20140343499 Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
11/20/2014US20140342996 Treatments for Gastrointestinal Disorders
11/20/2014US20140342995 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor
11/20/2014US20140342994 Fusion Protein Comprising Circularly Permuted Form Of Trail/Apo2L, Coding Gene And Use Thereof
11/20/2014US20140342992 Cell-Penetrating Peptides Having a Central Hydrophobic Domain
11/20/2014US20140342989 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
11/20/2014US20140342988 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment
11/20/2014US20140342987 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
11/20/2014US20140342986 Compositions and methods for treating diseases
11/20/2014US20140342985 Polymeric Devices for Controlled Release of Active Agents
11/20/2014US20140342981 Hepatic insulin sensitizing substance and test meal for insulin sensitization
11/20/2014US20140342980 Binding-site modified lectins and uses thereof
11/20/2014US20140342979 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140342978 Charged Nutritive Proteins and Methods
11/20/2014US20140342977 Compounds for proteasome enzyme inhibition
11/20/2014US20140342976 Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-beta superfamily members
11/20/2014US20140342975 Therapeutic Process For The Treatment Of The Metabolic Syndrome And Associated Metabolic Disorders
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 3163